New implant for heart failure could halve hospital readmission rates
A new device that allows doctors to detect early signs of deterioration in patients with heart failure could cut hospital readmissions by more than 50 per cent. The small wireless device known as CardioMEMS is implanted into the pulmonary artery. It remotely monitors changes in pressure that can indicate the build-up of fluid in a patient's body days before they experience symptoms such as…
A small wireless implant called CardioMEMS could cut hospital readmissions for heart failure patients by more than half. This device is implanted in the pulmonary artery and monitors pressure changes that signal fluid buildup, often days before symptoms like shortness of breath or fatigue appear. At Cleveland Clinic Abu Dhabi, two Emirati heart failure patients underwent the first procedures of their kind.
CardioMEMS offers early warning, enabling doctors to intervene before symptoms worsen, potentially avoiding hospital admissions and reducing mortality risks. Patients wear an electronic pillow that sends daily pressure readings to the heart failure team, who can adjust medications like diuretics to prevent fluid overload. This remote monitoring allows for timely treatment, potentially avoiding complications like infections or liver injuries.
However, CardioMEMS is not suitable for all patients, and the procedure is assessed on a case-by-case basis. Cleveland Clinic Abu Dhabi has performed 49 heart transplants since 2017, but remote monitoring aims to prevent the need for such extreme treatments.
Written by urgent.news from The National Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- New implant for heart failure could halve hospital readmission rates thenationalnews.com
